Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73 (1):17–48.

Article  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA-CANCER J CLIN. 2021;71 (3):209–49.

Article  PubMed  Google Scholar 

Arbour KC, Riely GJ. Systemic therapy for locally Advanced and Metastatic Non-Small Cell Lung Cancer: a review. JAMA-J AM MED ASSOC. 2019;322 (8):764–74.

Article  CAS  Google Scholar 

Lin D,Shen L, Luo M,Zhang K, Li J, Yang Q, Zhu F,Zhou D,Zheng S,Chen Y, Zhou J. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther. 2021;6(1):404.

Paget S. The distribution of secondary growths in cancer of the breast. 1889. CANCER METAST REV. 1989;8 (2):98–101.

CAS  Google Scholar 

Li W, Liu JB, Hou LK, Yu F, Zhang J, Wu W, Tang XM, Sun F, Lu HM, Deng J, et al. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. MOL CANCER. 2022;21 (1):25.

Article  PubMed  PubMed Central  Google Scholar 

Li SH, Wu MH, Wang HM, Hsu PC, Fang YF, Wang CL, Chu HC, Lin HC, Lee LY, Wu CY et al. Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study. INT J MOL SCI 2022, 23 (18).

Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158 (5):1110–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013;339 (6119):580–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei J, Deng W, Weng J, Li M, Lan G, Li X, Ye L, Wang Y, Liu F, Ou H, et al. Epithelial-mesenchymal transition classification of circulating tumor cells predicts clinical outcomes in progressive nasopharyngeal carcinoma. FRONT ONCOL. 2022;12:988458.

Article  PubMed  PubMed Central  Google Scholar 

Liu DG, Xue L, Li J, Yang Q, Peng JZ. Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer. CANCER BIOMARK. 2018;22 (3):417–26.

Article  CAS  PubMed  Google Scholar 

Li J, Liao Y, Ran Y, Wang G, Wu W, Qiu Y, Liu J, Wen N, Jing T, Wang H, et al. Evaluation of sensitivity and specificity of CanPatrol technology for detection of circulating tumor cells in patients with non-small cell lung cancer. BMC PULM MED. 2020;20 (1):274.

Article  PubMed  PubMed Central  Google Scholar 

Slusher AL, Kim JJ, Ribick M, Pollens-Voigt J, Bankhead A, Palmbos PL, Ludlow AT. Intronic Cis-element DR8 in hTERT is bound by splicing factor SF3B4 and regulates hTERT Splicing in Non-Small Cell Lung Cancer. MOL CANCER RES. 2022;20 (10):1574–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266 (5193):2011–5.

Article  CAS  PubMed  Google Scholar 

Schwartz LH, Litiere S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, et al. RECIST 1.1-Update and clarification: from the RECIST committee. EUR J CANCER. 2016;62:132–7.

Article  PubMed  PubMed Central  Google Scholar 

Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. NAT REV CLIN ONCOL. 2021;18 (10):663–72.

Article  PubMed  Google Scholar 

Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398 (10299):535–54.

Article  PubMed  Google Scholar 

Jacobsen MM, Silverstein SC, Quinn M, Waterston LB, Thomas CA, Benneyan JC, Han P. Timeliness of access to lung cancer diagnosis and treatment: a scoping literature review. Lung Cancer. 2017;112:156–64.

Article  PubMed  Google Scholar 

Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR, Feuer EJ. The effect of advances in lung-Cancer treatment on Population Mortality. NEW ENGL J MED. 2020;383 (7):640–9.

Article  CAS  PubMed  Google Scholar 

Tamminga M, de Wit S, Schuuring E, Timens W, Terstappen L, Hiltermann T, Groen H. Circulating tumor cells in lung cancer are prognostic and predictive for worse tumor response in both targeted- and chemotherapy. TRANSL LUNG CANCER R. 2019;8 (6):854–61.

Article  CAS  Google Scholar 

Fina E, Federico D, Novellis P, Dieci E, Monterisi S, Cioffi F, Mangiameli G, Finocchiaro G, Alloisio M, Veronesi G. Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and Have Differential Prognostic Significance in Non-Small Cell Lung Cancer. CANCERS 2021, 13 (17).

Guo W, Sun YF, Shen MN, Ma XL, Wu J, Zhang CY, Zhou Y, Xu Y, Hu B, Zhang M, et al. Circulating Tumor cells with stem-like phenotypes for diagnosis, prognosis, and therapeutic response evaluation in Hepatocellular Carcinoma. CLIN CANCER RES. 2018;24 (9):2203–13.

Article  CAS  PubMed  Google Scholar 

Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, Flejou JF, Lantuejoul S, Piaton E, Mourad N, Butori C, et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. CLIN CANCER RES. 2011;17 (4):827–35.

Article  CAS  PubMed  Google Scholar 

Wang PP, Liu SH, Chen CT, Lv L, Li D, Liu QY, Liu GL, Wu Y. Circulating tumor cells as a new predictive and prognostic factor in patients with small cell lung cancer. J CANCER. 2020;11 (8):2113–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tay RY, Fernandez-Gutierrez F, Foy V, Burns K, Pierce J, Morris K, Priest L, Tugwood J, Ashcroft L, Lindsay CR, et al. Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial. ANN ONCOL. 2019;30 (7):1114–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer. J THORAC ONCOL. 2016;11 (1):39–51.

Article  PubMed  Google Scholar 

Qi LN, Xiang BD, Wu FX, Ye JZ, Zhong JH, Wang YY, Chen YY, Chen ZS, Ma L, Chen J, et al. Circulating Tumor cells undergoing EMT provide a Metric for diagnosis and prognosis of patients with Hepatocellular Carcinoma. CANCER RES. 2018;78 (16):4731–44.

Article  CAS  PubMed  Google Scholar 

Barriere G, Riouallon A, Renaudie J, Tartary M, Rigaud M. Mesenchymal characterization: alternative to simple CTC detection in two clinical trials. ANTICANCER RES. 2012;32 (8):3363–9.

PubMed  Google Scholar 

Liang L, Liu Y, Jiang S, Huang J, He H, Shen L, Cong L, Jiang Y. Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma. J IMMUNOL RES 2022, 2022:6521290.

Sun WW, Xu ZH, Lian P, Gao BL, Hu JA. Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response. ONCOTARGETS THER. 2017;10:2413–24.

Article  CAS  Google Scholar 

Zhang Y, Men Y, Wang J, Xing P, Zhao J, Li J, Xu D, Hui Z, Cui W. Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC. J CANCER RES CLIN. 2022;148 (5):1137–46.

Article  CAS  Google Scholar 

Chen M, Xu R, Wu L, Chen X. Relationship between circulating tumor cells undergoing EMT and short-term efficacy following interventional treatment in patients with hepatocellular carcinoma. J Interv Med. 2020;3 (3):146–50.

PubMed  PubMed Central  Google Scholar 

Vazquez M, Altabas M, Moreno DC, Geng AA, Perez-Hoyos S, Giralt J. 30-Day mortality following palliative Radiotherapy. FRONT ONCOL. 2021;11:668481.

Article  PubMed  PubMed Central  Google Scholar 

Punnoose EA, Atwal S, Liu W, Raja R, Fine BM, Hughes BG, Hicks RJ, Hampton GM, Amler LC, Pirzkall A, et al. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. CLIN CANCER RES. 2012;18 (8):2391–401.

Article  CAS  PubMed  Google Scholar 

Matikas A, Souglakos J, Katsaounis P, Kotsakis A, Kouroupakis P, Pantazopoulos N, Kentepozidis N, Nikolaidi A, Messaritakis I, Tzovara I, et al. MINOAS: a single-arm translational phase II trial of FOLFIRI Plus Aflibercept as First-line therapy in Unresectable, metastatic colorectal Cancer. TARGET ONCOL. 2019;14 (3):285–93.

Article  PubMed  Google Scholar 

de Kruijff IE, Sieuwerts AM, Onstenk W, Kraan J, Smid M, Van MN, van der Vlugt-Daane M, Hoop EO, Mathijssen R, Lolkema MP et al. Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel. CANCERS 2019, 11 (8).

Chang PH, Lee CH, Wu TM, Yeh KY, Wang HM, Huang WK, Chan SC, Chou WC, Kuan FC, Kuo HC, et al. Association of early changes of circulating cancer stem-like cells with survival among patients with metastatic breast cancer. THER ADV MED ONCOL. 2022;14:7445082.

Article  Google Scholar 

You R, Liu YP, Lin M, Huang PY, Tang LQ, Zhang YN, Pan Y, Liu WL, Guo WB, Zou X, et al. Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients. INT J CANCER. 2019;145 (10):2873–83.

Article  CAS  PubMed  Google Scholar 

Lee CH, Hsieh JC, Wu TM, Yeh TS, Wang HM, Lin YC, Chen JS, Lee CL, Huang WK, Hung TM, et al. Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer. BMC Cancer. 2019;19 (1):1167.

Article  CAS  PubMed  PubMed Central  Google Scholar